Conferences

A Leading Competitive and Market Intelligence conference – The only gathering of senior level professionals from Pharma, Biotech and Device professionals looking for the latest updates and learn about the most critical and relevant issues facing the competitive & Market Intelligence community. The conference theme is “Driving the future of Pharma Business through Competitive & Market Intelligence”. The conference aims to understand how the pharmaceutical & Biotech companies, marketing, competitive intelligence, strategic and operational divisions are staying updated with accurate information about their competitors in today’s dynamic Market to keep themselves ahead and deliver business value. It will also discuss major issues and unveil solutions to the challenges faced by today’s CI professionals in the industry. Listen to the dynamic leaders and industry expert discussing and presenting case studies for best practices. Pharma CMI also gives an opportunity to meet and network with Industry thought leaders & peers within Competitive Intelligence Industry in one location.  IF you are interested to learn how to utilize competitive & market Intelligence to keep yourself ahead in 2017 and beyond to boost your business.

Clinical Operations in Oncology Trials (CTO) is the only operationally-focused oncology conference in the USA. Alongside our West Coast conference, the East Coast conference in the Boston biotech hub is tailored specifically for Clinical Operations/Development/Research and Medical Affairs pharma and biotech representatives in the region.  With a dynamic programme written for the industry, by the industry, our 7th annual CTO East Coast event and promises to be an engaging and memorable conference. Optimizing clinical processes within oncology trials to ensure effective patient recruitment, trial management and achieve trial success is central to this year’s conference.

OCT Medical Devices moved to Irvine, California for the first year in 2016, and we are pleased to say it proved a resounding success. As the only event to cater for the Southern California Medical device hub in Irvine, it brought together a variety of medical device companies of all sizes, including Medtronic, Edwards Lifesciences, Onciomed, Inc and St Jude Medical.  The encompassing agenda focussed on the most pressing topics within the industry, from emerging markets to medical device reimbursement, and it still stands as one of the leading clinical focussed events which encompasses discussions across the med-device industry.

North East Pharmaceutical Convention (NEPC) is a sincere initiative of Pharmacists from all sectors of the Pharmacy Profession of North Eastern states to create a platform for deliberating various issues related to Industry, regulatory, academia, hospital pharmacy and other related fields. North East due to its topographical location and connectivity with South Asian Nations has potential to be a major Pharmaceutical Hub of the country and can have significant contributions to the country export. NEPC is an effort to expose the potential of this region to get transformed into a Pharmaceutical Hub in the country under the Act East Policy launched in Nov 2014 and Make In India policy of the Government of India and thereby parade for North East Industrial Investment Promotion Policy (NEIIPP) to rejuvenate vibrant NE Region. This shall be helpful in creating awareness and more job opportunities for the thousands of aspiring Pharmacy professionals (e.g. D. Pharm, B. Pharm, M. Pharm, Pharm.D, PhD.) of the region. The NEPC is an attempt to evolve collective wisdom of Pharmacy Professionals of the region for formulating newer policies in the relevant fields and for the betterment of the profession and health care system.

About Parul University
Parul University was established under Gujarat Private University Act 2009, after legislation passed by the Government of Gujarat on 26th March 2015 giving University status to Parul Group of Institutes functioning under the aegis of Parul Arogya Seva Mandal Trust. Parul University is an amalgamation on 28 Institutes offering 100+ programs in Engineering & Technology, Pharmacy, Physiotherapy, Homoeopathy, Ayurveda, Architecture, Management, Business Administration, Computer Application, Fine Arts, Social Work and Vocational Education at Diploma, Under Graduate, Post Graduate & Doctoral Level in a 150+ acre fully equipped campus housing 25000+ students, 300+ International Students from 26 Different Countries, 2000+ faculty members & providing in-campus residential facility to 7000+ students making it India's Premier Multidisciplinary University. Nevertheless the fact is that it is the only institution in Gujaratto have 109 faculty members from reputed organizations such as NTs & NITs.

UBM India is India's leading exhibition organizer that provides the industry with platforms that bring together buyers and sellers from around the world, through a portfolio of exhibitions, content led conferences & seminars. UBM India hosts over 20 large scale exhibitions and 40 conferences across the country every year; thereby enabling trade across multiple industry verticals. A UBM Asia Company, UBM India has offices across Mumbai, New Delhi, Bangalore and Chennai. UBM Asia is owned by UBM plc which is listed on the London Stock Exchange. UBM Asia is the leading exhibition organizer in Asia and the biggest commercial organizer in mainland China, India and Malaysia

UBM India the organisers of InnoPack Pharma Confex are pleased to announce the 2nd Edition of India Packaging Awards.  As India’s first & only packaging Awards this initiative is dedicated to honouring the revolutionary and inspiring innovations of radical thinkers of the industry who drive this thriving industry’s success.

As we enter into 2017, various changes in the industry have altered the landscape for clinical trial supply businesses.  With this in mind, our team has developed an extensive and informative agenda to ensure you leave with various concepts to improve your clinical trial supply chain in the ever changing environment.

Effective forecasting, risks of temperature deviation and annex 16 are just some of the latest challenges which many clinical trial supply businesses are facing today; the consequences which can occur due to ineffective strategies can lead to start up delays, stock outs and most importantly rise in costs. At this year’s event, we aim to embark upon these implications and many more to provide all our attendees with valuable insight into innovative strategies to raise the performance of your clinical trial supply operations.

GALGOTIAS UNIVERSITY
Galgotias University has been transcending new boundaries in education, research and placements since its inception in 2011. The University, which is based in Greater Noida. has an enrollment of over 15.000 students across more than 80 Undergraduate and Post Graduate programs. Galgotias has very recently been ranked 6th by India Today among top 10 emerging institutions of India (as per its issue dated May 30th 2016). Previously too. Galgotias University has been ranked among the top institutions of India by leading media surveys. Galgotias University has also been awarded for excellence in academics and placement by Dataquest Cybermedia at the Dataquest Cybermedia ICT Awards 2016. Galgotias has also been ranked No.2 among Emerging Engineering Institutes m India by limes Engineering Survey. 2016 while its School of Business has been awarded among top 5 B.Schools by Times B.School Ranking 2016.

ISPOR is the leading global professional society in Pharmacoeconomics and Outcomes Research Founded in 1995 as an international multidisciplinary professional membership society, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) advances the policy, science, and practice of pharmacoeconomics (health economics) and outcomes research (the scientific discipline that evaluates the effect of health care interventions on patient well-being including clinical, economic, and patient-centered outcomes) ispor.org. With a 20-year commitment to education, collaboration, and leadership, ISPOR meetings, published resources, and facilitated discussions have evolved as the leading resources for health economics and outcomes research. Moreover, as an unbiased organization of 9,500 individual and student members from 114 countries, and over 8,700 affiliate members from our Regional Chapters ispor.org/RegionalChapters, ISPOR members represent the entire field including research, academia, decision and policy makers, consultants, payers, patient representative groups, and others. ISPOR is a non-profit 501(c) (3) public organization for educational and scientific purposes, as defined by the US IRS.